Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Coulson, J. Caulkins (2012)
Scheduling of newly emerging drugs: a critical review of decisions over 40 years.Addiction, 107 4
Matt Anderson (2014)
European Monitoring Centre for Drugs and Drug Addiction
Michelle Lafrance (2007)
A Bitter PillJournal of Health Psychology, 12
S. Hill, T. Doris, S. Gurung, Stephen Katebe, A. Lomas, M. Dunn, P. Blain, Simon Thomas (2013)
Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case seriesClinical Toxicology, 51
A. Winstock, L. Mitcheson (2012)
New recreational drugs and the primary care approach to patients who use themBMJ : British Medical Journal, 344
P. Kavanagh, J. Power (2014)
New psychoactive substances legislation in Ireland - Perspectives from academia.Drug testing and analysis, 6 7-8
F. Schifano (2004)
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalitiesPsychopharmacology, 173
David Khey, J. Stogner, B. Miller (2014)
New Trends in Psychoactive Drug Use
F. Bersani, O. Corazza, Gabriella Albano, G. Valeriani, R. Santacroce, Flaminia Posocco, E. Cinosi, P. Simonato, G. Martinotti, G. Bersani, F. Schifano (2014)
25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic DrugBioMed Research International, 2014
D. Papanti, F. Schifano, G. Botteon, F. Bertossi, Jason Mannix, D. Vidoni, M. Impagnatiello, E. Pascolo-Fabrici, Tommaso Bonavigo (2013)
“Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case reportHuman Psychopharmacology: Clinical and Experimental, 28
Purpose – The purpose of this paper is to describe and summarize the recent emergence of NPS onto the drug market. To show the international and national responses, legal and guidance. To indicate some of the challenges NPS present to jurisdictions. To indicate some of the challenges NPS present to treatment agencies. To outline what is known about prevalence and effects. Design/methodology/approach – A narrative account of the substances becoming known and the response made by jurisdictions. Findings – The use and effects of NPS are slowly becoming known and exchanged between jurisdictions and treatment agencies. The user group appears to differ from the “traditional” substance users groups with which agencies are familiar. The use of the internet is a characteristic of this new market and user group. Research limitations/implications – New substances are constantly being identified. Previous treatment approaches may not be fully relevant to NPS. The new area of cognition enhancement is being gradually realized. Practical implications – Treatment agencies need to develop new approaches, both to treat the effects of NPS use and to attract NPS users, who do not identify as “drug users”. Social implications – A new user group appears to be emerging. Cognition enhancement is a feature of NPS composition and use/attraction. Originality/value – An attempt to summarize existing understanding of NPS use and marketing and to predict future trends and needs.
Drugs and Alcohol Today – Emerald Publishing
Published: Mar 2, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.